Back to Search Start Over

CO129 Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy (RWPC) for Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM).

Authors :
Krishnan, A.
Nooka, A.
Chari, A.
Garfall, A.L.
Martin, T.
Nair, S.
Lin, X.
Qi, K.
Londhe, A.
Pei, L.
Ammann, E.
Chastain, K.
Parekh, T.
Marshall, A.
Slavcev, M.
Usmani, S.Z.
Source :
Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS37-S37. 1p.
Publication Year :
2023

Subjects

Subjects :
*MULTIPLE myeloma
*PHYSICIANS

Details

Language :
English
ISSN :
10983015
Volume :
26
Issue :
12
Database :
Academic Search Index
Journal :
Value in Health
Publication Type :
Academic Journal
Accession number :
174417153
Full Text :
https://doi.org/10.1016/j.jval.2023.09.201
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details